Stopping Cardiovascular Treatments and Mortality in a MICU (TRAM)

Regional University Hospital Center (CHRU)

Status: Unknown

Conditions: Critical Care; Medication; Cardiovascular Diseases; Outcome, Fatal

Treatments: Other: Observation

Study type: Observational

Funder types: Other

Identifiers

NCT04121429

TRAM ( 29BRC19.0035)

Details and patient eligibility

About

Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted and/or modified. The question of the study is to investigate wether such treatment interruption might be responsible for prognosis modifications.

Full description

Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted and/or modified.

Few studies have investigated the outcome impact of medications interruption and/or modifications following hospital admission. We did consider that it might be interesting to study whether treatment continuation, interruption, and/or re-introduction following ICU admission may modify patients' outcome either in the ICU or following hospital discharge (at 3,6 and 12 months).

Enrollment: 150 estimated patients

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients with cardiovascular treatment prior to ICU admission

Exclusion criteria

• Data unavailability
• Consent withdrawal following information